Collaboration - October 16, 2015
Nextera collaborates with Johnson & Johnson
Norwegian Nextera has entered into a research agreement with Janssen Biotech, one of the Janssen Pharmaceutical Companies of Johnson & Johnson. Nextera is a biotechnology company focused on developing novel and highly disease-specific immunotherapies for autoimmune diseases, cancer and chronic infections. Under terms of the agreement, Nextera will, with use of its unique technology platform, […]